Naqi Lian

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies.

Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies.

Journal: Pharmacology research & perspectives

Published: October 24, 2025

Glycyrrhetinic acid orchestrates ERS-pyroptosis crosstalk to elicit immunogenic cell death in hepatocellular carcinoma.

Glycyrrhetinic acid orchestrates ERS-pyroptosis crosstalk to elicit immunogenic cell death in hepatocellular carcinoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 30, 2025

Metabolic cell death in cancer: mechanisms and therapeutic potential.

Metabolic cell death in cancer: mechanisms and therapeutic potential.

Journal: Apoptosis : an international journal on programmed cell death

Published: May 06, 2025

Liguzinediol potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis to ameliorate cardiotoxicity.

Liguzinediol potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis to ameliorate cardiotoxicity.

Journal: Chinese medicine

Published: January 30, 2024

Ligustrazine and liguzinediol protect against doxorubicin-induced cardiomyocytes injury by inhibiting mitochondrial apoptosis and autophagy.

Ligustrazine and liguzinediol protect against doxorubicin-induced cardiomyocytes injury by inhibiting mitochondrial apoptosis and autophagy.

Journal: Clinical and experimental pharmacology & physiology

Published: April 19, 2023

Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.

Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.

Journal: Annals of translational medicine

Published: October 18, 2022

Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.

Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.

Journal: Acta histochemica

Published: April 23, 2022

Curcumol Suppresses CCF-Mediated Hepatocyte Senescence Through Blocking LC3B-Lamin B1 Interaction in Alcoholic Fatty Liver Disease.

Curcumol Suppresses CCF-Mediated Hepatocyte Senescence Through Blocking LC3B-Lamin B1 Interaction in Alcoholic Fatty Liver Disease.

Journal: Frontiers in pharmacology

Published: April 04, 2022

LncRNA MAYA promotes iron overload and hepatocyte senescence through inhibition of YAP in non-alcoholic fatty liver disease.

LncRNA MAYA promotes iron overload and hepatocyte senescence through inhibition of YAP in non-alcoholic fatty liver disease.

Journal: Journal of cellular and molecular medicine

Published: March 16, 2021

Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1.

Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1.

Journal: British journal of pharmacology

Published: February 03, 2020

Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress.

Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress.

Journal: Apoptosis : an international journal on programmed cell death

Published: September 21, 2019

Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin-1 signaling.

Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin-1 signaling.

Journal: IUBMB life

Published: April 28, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026